Elsevier

Progress in Neurobiology

Volume 69, Issue 3, February 2003, Pages 193-211
Progress in Neurobiology

Proteomics in brain research: potentials and limitations

https://doi.org/10.1016/S0301-0082(03)00036-4Get rights and content

Abstract

The advent of proteomics techniques has been enthusiastically accepted in most areas of biology and medicine. In neuroscience, a host of applications was proposed ranging from neurotoxicology, neurometabolism, determination of the proteome of the individual brain areas in health and disease, to name a few. Only recently, the limitations of the method have been shown, hampering the rapid spreading of the technology, which in principle consists of two-dimensional gel electrophoresis with in-gel protein digestion of protein spots and identification by mass-spectrometrical approaches or microsequencing. The identification, including quantification using specific software, of brain protein classes, like enzymes, cytoskeleton proteins, heat shock proteins/chaperones, proteins of the transcription and translation machinery, synaptosomal proteins, antioxidant proteins, is a clear domain of proteomics. Furthermore, the concomitant detection of several hundred proteins on a gel allows the demonstration of an expressional pattern, rather generated by a reliable, protein-chemical method than by immunoreactivity, proposed by protein-arrays. An additional advantage is that hitherto unknown proteins, so far only proposed from their nucleic acid structure, designated as hypothetical proteins, can be identified as brain proteins. As to shortcomings and disadvantages of the method we would point to the major problem, the failure to separate hydrophobic proteins. There is so far no way to analyse the vast majority of these proteins in gels. Several other analytical problems need to be overcome, but once the latter problem can be solved, there is nothing to stop the method for a large scale analysis of membrane proteins in neuroscience.

Introduction

Proteomics is the science and methodology of the study of the proteome, i.e. all proteins expressed in a cell or tissue, rather than proteins one by one. The advent of proteomics was a major step forward, comparable to the introduction of molecular biological methods in the past. It fits within the concept that the determination of protein rather than RNA levels has major advantages as it is the proteins that carry out functions. There is a long and unpredictable way from RNA to protein, a fact known to all scientists working with gene hunting methods, like differential display and subtractive hybridization. Huge subtractive libraries have been generated, but when the differentially expressed mRNAs were studied at the protein level, only a small percentage of aberrant transcriptomes could be verified. This does not mean, of course, that proteomics is fully replacing these techniques, but proteomics is a very valuable tool for protein hunting, i.e. comparing cell and tissue proteomes under physiological and pathophysiological conditions. The trend, however, seems to be that once the protein is determined, the transcriptional level is examined to find the underlying mechanism for the increase or decrease of a certain gene product. Moreover, information about the presence of isoforms and post-translational modifications can be obtained by proteomics.

In the following, we give only an outline, an example of a proteomic method that has been used in many studies, and we are aware that much valuable work is not mentioned and many important studies are not cited. The review is written to enable the neuroscientist to catch the spirit of proteomics. After introducing the methodology, we present typical human brain protein maps, identify the protein classes, recommend applications, discuss the shortcomings and limitations of proteomics, and, finally, draw a conclusion.

Section snippets

Typical analytical protocols for brain proteomics

Proteomics consists mainly of two steps: (1) separation of proteins usually by two-dimensional gel electrophoresis and (2) protein analysis and identification, mainly by mass spectrometry. Of course, other protein identification methods, like amino acid composition analysis, N-terminal sequencing, or immunochemistry, as well as column chromatography can be used (Fountoulakis, 2001), or other biochemical techniques can be applied for protein enrichment (Fountoulakis and Takács, 2002).

A critical

Generation of a human brain protein map

To illustrate results of proteomics, we provide a practical example of an application by showing typical brain protein maps from normal human frontal cortex after subfractionation into mitochondrial, microsomal and cytosolic fractions (Fig. 1, Fig. 2, Fig. 3, respectively). In Table 1, we provide data for protein identification assignment, including peptide matches, probability of assignment of a random identity and theoretical pI and molecular weight values. Analysis of spots from the three

Cytoskeleton proteins

Cytoskeleton proteins (CP) are not only serving as scaffolding structures but also play a major role in transport and signalling (dos Remedios and Thomas, 2001). Reports about the separation and identification of CP have been published for several organ systems (Srinivasan et al., 2001, Kovarova et al., 2000, Steiner et al., 2000), including the brain (Weitzdoerfer et al., 2001, Weitzdoerfer et al., 2002, Lubec et al., 2001, Gulesserian et al., 2002), and for several cellular compartments.

Potential applications

There is a wide range of proteomics applications in neuroscience, and with the rapid development in the area, many more can be expected in the near future. First of all, proteomics can be used for protein screening in brain tissue, which may be extended to the generation of protein maps. It also can be applied for the determination of isoforms and post-translational modifications. Protein spots can be excised from the gels and further examined for post-translational modifications, i.e.

Limitations

A series of shortcomings and limitations must be indicated to prevent raising hopes and expectations too high for this methodology.

Conclusion and perspectives

This review was written to give some insight into proteomics and to catch the spirit of proteomics rather than to list the many technologies that are available or are in progress, and, therefore, many important contributions have not been respected. Proteomics is a rapidly developing area and will not only successfully complement genomics but hold centre stage. Determination of proteins is much closer to function than that of RNAs. This technology enabling high throughput and automation (

Acknowledgements

G.L. is highly indebted to the Red Bull Company, Salzburg, Austria, for support of the proteome project. We are highly indebted to Mrs. Claudia Mostoegl for excellent secretarial work.

References (98)

  • J. Kyte et al.

    A simple method for displaying the hydropathic character of a protein

    J. Mol. Biol.

    (1982)
  • F. Le Naour et al.

    Profiling changes in gene expression during differentiation and maturation of monocyte-derived dendritic cells using both oligonucleotide microarrays and proteomics

    J. Biol. Chem.

    (2001)
  • T.S. Lewis et al.

    Identification of novel MAP kinase pathway signalling targets by functional proteomics and mass spectrometry

    Mol. Cell

    (2000)
  • S. Loughrey Chen et al.

    Mass spectrometry-based methods for phosphorylation site mapping of hyperphosphorylated proteins applied to Net1, a regulator of exit from mitosis in yeast

    Mol. Cell Proteomics

    (2002)
  • B. Lubec et al.

    Manifold reduction of moesin in fetal Down syndrome brain

    Biochem. Biophys. Res. Commun.

    (2001)
  • M.P. Molloy

    Two-dimensional electrophoresis of membrane proteins using immobilized pH gradients

    Anal. Biochem.

    (2000)
  • T. Rabilloud et al.

    Proteomics analysis of cellular response to oxidative stress. Evidence for in vivo overoxidation of peroxiredoxins at their active site

    J. Biol. Chem.

    (2002)
  • E. Schuller et al.

    Brain t-complex polypeptide 1 (TCP-1) related to its natural substrate beta1 tubulin is decreased in Alzheimer’s disease

    Life Sci.

    (2001)
  • R.J. Simpson et al.

    Cancer proteomics: from signalling networks to tumor markers

    Trends Biotechnol.

    (2001)
  • R. Vlkolinsky et al.

    Decreased brain levels of 2′,3′-cyclic nucleotide-3′-phosphodiesterase in Down syndrome and Alzheimer’s disease

    Neurobiol. Aging

    (2001)
  • R. Weitzdoerfer et al.

    Reduction of actin-related protein complex 2/3 in fetal Down syndrome brain

    Biochem. Biophys. Res. Commun.

    (2002)
  • B.C. Yoo et al.

    Deranged expression of molecular chaperones in brains of patients with Alzheimer’s disease

    Biochem. Biophys. Res. Commun.

    (2001)
  • G.C. Adam et al.

    Proteomic profiling of mechanistically distinct enzyme classes using a common chemotype

    Nat. Biotechnol.

    (2002)
  • M. Bajo et al.

    Neurofilament proteins NF-L, NF-M and NF-H in brain of patients with Down syndrome and Alzheimer’s disease

    Amino Acids

    (2001)
  • M. Bajo et al.

    Proteomic evaluation of intermediary metabolism enzyme proteins in fetal Down’s syndrome cerebral cortex

    Proteomics

    (2002)
  • M. Belghazi et al.

    Analysis of protein sequences and protein complexes by matrix-assisted laser desorption/ionization mass spectrometry

    Proteomics

    (2001)
  • S. Bellanger et al.

    Stability of the human papillomavirus type 18 E2 protein is regulated by a proteasome degradation pathway through its amino-terminal transactivation domain

    J. Virol.

    (2001)
  • P. Berndt et al.

    Reliable automatic protein identification from matrix-assisted laser desorption/ionization mass spectrometric peptide fingerprints

    Electrophoresis

    (1999)
  • A.R. Bicknese et al.

    Human umbilical cord blood cells can be induced to express markers for neurons and glia

    Cell Transplant.

    (2002)
  • J. Bies et al.

    Oncogenic activation of c-Myb by carboxyl-terminal truncation leads to decreased proteolysis by the ubiquitin-26S proteasome pathway

    Oncogene

    (1997)
  • P.S. Brookes et al.

    High throughput two-dimensional blue-native electrophoresis: a tool for functional proteomics of mitochondria and signalling complexes

    Proteomics

    (2002)
  • M. Chevallet et al.

    New zwitterionic detergents improve the analysis of membrane proteins by two-dimensional electrophoresis

    Electrophoresis

    (1998)
  • X.F. Csar et al.

    Copper/zinc superoxide dismutase is phosphorylated and modulated specifically by granulocyte-colony stimulating factor in myeloid cells

    Proteomics

    (2001)
  • dos Remedios, C.G., Thomas, D.D., 2001. Molecular Interactions of Actin. Springer, Berlin, Heidelberg, pp....
  • K. Dua et al.

    Translational control of the proteome: relevance to cancer

    Proteomics

    (2001)
  • S. Evers et al.

    Mechanism-related changes in the gene transcription and protein synthesis patterns of Haemophilus influenzae after treatment with transcriptional and translational inhibitors

    Proteomics

    (2001)
  • M. Ferro et al.

    Organic solvent extraction as a versatile provedure to identify hydrophobic chloroplast membrane proteins

    Electrophoresis

    (2000)
  • Fountoulakis, M., 2000. Two-dimensional electrophoresis. Encyclopedia of Separation Science, II/Electrophoresis....
  • M. Fountoulakis

    Proteomics: current technologies and applications in neurological disorders and toxicology

    Amino Acids

    (2001)
  • M. Fountoulakis et al.

    Proteomic analysis of the cell envelope fraction of Escherichia coli

    Amino Acids

    (2003)
  • M. Fountoulakis et al.

    Effect of strong detergents and chaotropes on the protein detection in two-dimensional gels

    Electrophoresis

    (2001)
  • M. Fountoulakis et al.

    Large-scale identification of proteins of Haemophilus influenzae by amino acid composition analysis

    Electrophoresis

    (1997)
  • M. Fountoulakis et al.

    Two-dimensional map of Haemophilus influenzae following protein enrichment by Heparin chromatography

    Electrophoresis

    (1997)
  • M. Fountoulakis et al.

    Reference map of the low-molecular-mass proteins of Haemophilus influenzae

    Electrophoresis

    (1998)
  • M. Fratelli et al.

    Identification by redox proteomics of glutathionylated proteins in oxidatively stressed human T lymphocytes

    Proc. Natl. Acad. Sci. U.S.A.

    (2002)
  • K. Gevaert et al.

    Protein identification methods in proteomics

    Electrophoresis

    (2000)
  • S. Greber et al.

    Decreased levels of synaptosomal-associated protein 25 in the brain of patients with Down syndrome and Alzheimer’s disease

    Electrophoresis

    (1999)
  • T. Gulesserian et al.

    Superoxide dismutase SOD1, encoded on chromosome 21, but not SOD2 is overexpressed in brains of patients with Down syndrome

    J. Investig. Med.

    (2001)
  • X. Guo et al.

    Proteomic characterization of early-stage differentiation of mouse embryonic stem cells into neural cells induced by all-trans retinoic acid in vitro

    Electrophoresis

    (2001)
  • Cited by (153)

    • Uncovering Neurodegenerative Protein Modifications via Proteomic Profiling

      2015, International Review of Neurobiology
      Citation Excerpt :

      We then used iTRAQ technology together with a multiplexing strategy which detected the fragmented ions of mass tags that generated a reporter ion in one of four different channels on the tandem mass spectra (Ong & Mann, 2005; Ross et al., 2004; Fig. 2). Use of quantitative proteomics to profile the human brain proteome presents clear advantages, since this discovery-driven approach can generate unforeseen insight into disease pathology which is likely to be overlooked by classical hypothesis-driven research (Lubec, Krapfenbauer, & Fountoulakis, 2003). The discovery-driven approach also has the advantage of being unbiased by prior assumptions, thus allowing the analysis and comparison between experimental conditions and data from thousands of individual peptides and proteins.

    • Cellular and molecular neurotoxicology: Basic principles

      2009, Clinical Neurotoxicology: Syndromes, Substances, Environments
    • Omics in precision medicine

      2023, Oncology: Genomics, Precision Medicine and Therapeutic Targets
    View all citing articles on Scopus
    View full text